ReviewTherapeutics and clinical risk management2016
New combinations in the treatment of COPD: rationale for aclidinium-formoterol.
Cristoforo Incorvaia et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it